List of Tables
Table 1. Global Sibling DNA Tests Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
Table 2. Global Sibling DNA Tests Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
Table 3. Global Sibling DNA Tests Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 4. Global Sibling DNA Tests Revenue by Region (2020-2025) & (US$ Million)
Table 5. Global Sibling DNA Tests Revenue by Region (2026-2031) & (US$ Million)
Table 6. Emerging Market Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 7. Global Sibling DNA Tests Revenue by Players (2020-2025) & (US$ Million)
Table 8. Global Sibling DNA Tests Revenue Market Share by Players (2020-2025)
Table 9. Global Key Players’Ranking Shift (2023 vs. 2024) (Based on Revenue)
Table 10. Global Sibling DNA Tests by Player Tier (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Sibling DNA Tests as of 2024)
Table 11. Global Sibling DNA Tests Average Gross Margin (%) by Player (2020 VS 2024)
Table 12. Global Sibling DNA Tests Companies Headquarters
Table 13. Global Sibling DNA Tests Market Concentration Ratio (CR5 and HHI)
Table 14. Key Market Entrant/Exit (2020-2024) – Drivers & Impact Analysis
Table 15. Key Mergers & Acquisitions, Expansion Plans, R&D Investment
Table 16. Global Sibling DNA Tests Revenue by Type (2020-2025) & (US$ Million)
Table 17. Global Sibling DNA Tests Revenue by Type (2026-2031) & (US$ Million)
Table 18. Key Product Attributes and Differentiation
Table 19. Global Sibling DNA Tests Revenue by Application (2020-2025) & (US$ Million)
Table 20. Global Sibling DNA Tests Revenue by Application (2026-2031) & (US$ Million)
Table 21. Sibling DNA Tests High-Growth Sectors Demand CAGR (2024-2031)
Table 22. Top Customers by Region
Table 23. Top Customers by Application
Table 24. North America Sibling DNA Tests Growth Accelerators and Market Barriers
Table 25. North America Sibling DNA Tests Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 26. Europe Sibling DNA Tests Growth Accelerators and Market Barriers
Table 27. Europe Sibling DNA Tests Revenue Grow Rate (CAGR) by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 28. Asia-Pacific Sibling DNA Tests Growth Accelerators and Market Barriers
Table 29. Asia-Pacific Sibling DNA Tests Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 30. Central and South America Sibling DNA Tests Investment Opportunities and Key Challenges
Table 31. Central and South America Sibling DNA Tests Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 32. Middle East and Africa Sibling DNA Tests Investment Opportunities and Key Challenges
Table 33. Middle East and Africa Sibling DNA Tests Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 34. AlphaBiolabs Corporation Information
Table 35. AlphaBiolabs Description and Major Businesses
Table 36. AlphaBiolabs Product Features and Attributes
Table 37. AlphaBiolabs Revenue (US$ Million) and Gross Margin (2020-2025)
Table 38. AlphaBiolabs Revenue Proportion by Product in 2024
Table 39. AlphaBiolabs Revenue Proportion by Application in 2024
Table 40. AlphaBiolabs Revenue Proportion by Geographic Area in 2024
Table 41. AlphaBiolabs Sibling DNA Tests SWOT Analysis
Table 42. AlphaBiolabs Recent Developments
Table 43. Laboratory Corporation Corporation Information
Table 44. Laboratory Corporation Description and Major Businesses
Table 45. Laboratory Corporation Product Features and Attributes
Table 46. Laboratory Corporation Revenue (US$ Million) and Gross Margin (2020-2025)
Table 47. Laboratory Corporation Revenue Proportion by Product in 2024
Table 48. Laboratory Corporation Revenue Proportion by Application in 2024
Table 49. Laboratory Corporation Revenue Proportion by Geographic Area in 2024
Table 50. Laboratory Corporation Sibling DNA Tests SWOT Analysis
Table 51. Laboratory Corporation Recent Developments
Table 52. International Biosciences Corporation Information
Table 53. International Biosciences Description and Major Businesses
Table 54. International Biosciences Product Features and Attributes
Table 55. International Biosciences Revenue (US$ Million) and Gross Margin (2020-2025)
Table 56. International Biosciences Revenue Proportion by Product in 2024
Table 57. International Biosciences Revenue Proportion by Application in 2024
Table 58. International Biosciences Revenue Proportion by Geographic Area in 2024
Table 59. International Biosciences Sibling DNA Tests SWOT Analysis
Table 60. International Biosciences Recent Developments
Table 61. Validity Genetics Corporation Information
Table 62. Validity Genetics Description and Major Businesses
Table 63. Validity Genetics Product Features and Attributes
Table 64. Validity Genetics Revenue (US$ Million) and Gross Margin (2020-2025)
Table 65. Validity Genetics Revenue Proportion by Product in 2024
Table 66. Validity Genetics Revenue Proportion by Application in 2024
Table 67. Validity Genetics Revenue Proportion by Geographic Area in 2024
Table 68. Validity Genetics Sibling DNA Tests SWOT Analysis
Table 69. Validity Genetics Recent Developments
Table 70. DNAQ Corporation Information
Table 71. DNAQ Description and Major Businesses
Table 72. DNAQ Product Features and Attributes
Table 73. DNAQ Revenue (US$ Million) and Gross Margin (2020-2025)
Table 74. DNAQ Revenue Proportion by Product in 2024
Table 75. DNAQ Revenue Proportion by Application in 2024
Table 76. DNAQ Revenue Proportion by Geographic Area in 2024
Table 77. DNAQ Sibling DNA Tests SWOT Analysis
Table 78. DNAQ Recent Developments
Table 79. EasyDNA Corporation Information
Table 80. EasyDNA Description and Major Businesses
Table 81. EasyDNA Product Features and Attributes
Table 82. EasyDNA Revenue (US$ Million) and Gross Margin (2020-2025)
Table 83. EasyDNA Recent Developments
Table 84. PaternityUSA Corporation Information
Table 85. PaternityUSA Description and Major Businesses
Table 86. PaternityUSA Product Features and Attributes
Table 87. PaternityUSA Revenue (US$ Million) and Gross Margin (2020-2025)
Table 88. PaternityUSA Recent Developments
Table 89. Crystal Health Group Corporation Information
Table 90. Crystal Health Group Description and Major Businesses
Table 91. Crystal Health Group Product Features and Attributes
Table 92. Crystal Health Group Revenue (US$ Million) and Gross Margin (2020-2025)
Table 93. Crystal Health Group Recent Developments
Table 94. NorthGene Corporation Information
Table 95. NorthGene Description and Major Businesses
Table 96. NorthGene Product Features and Attributes
Table 97. NorthGene Revenue (US$ Million) and Gross Margin (2020-2025)
Table 98. NorthGene Recent Developments
Table 99. Cellmark Corporation Information
Table 100. Cellmark Description and Major Businesses
Table 101. Cellmark Product Features and Attributes
Table 102. Cellmark Revenue (US$ Million) and Gross Margin (2020-2025)
Table 103. Cellmark Recent Developments
Table 104. Genebase Corporation Information
Table 105. Genebase Description and Major Businesses
Table 106. Genebase Product Features and Attributes
Table 107. Genebase Revenue (US$ Million) and Gross Margin (2020-2025)
Table 108. Genebase Recent Developments
Table 109. SecuriGene Corporation Information
Table 110. SecuriGene Description and Major Businesses
Table 111. SecuriGene Product Features and Attributes
Table 112. SecuriGene Revenue (US$ Million) and Gross Margin (2020-2025)
Table 113. SecuriGene Recent Developments
Table 114. Genex Diagnostics Corporation Information
Table 115. Genex Diagnostics Description and Major Businesses
Table 116. Genex Diagnostics Product Features and Attributes
Table 117. Genex Diagnostics Revenue (US$ Million) and Gross Margin (2020-2025)
Table 118. Genex Diagnostics Recent Developments
Table 119. Genovate Corporation Information
Table 120. Genovate Description and Major Businesses
Table 121. Genovate Product Features and Attributes
Table 122. Genovate Revenue (US$ Million) and Gross Margin (2020-2025)
Table 123. Genovate Recent Developments
Table 124. AffinityDNA Corporation Information
Table 125. AffinityDNA Description and Major Businesses
Table 126. AffinityDNA Product Features and Attributes
Table 127. AffinityDNA Revenue (US$ Million) and Gross Margin (2020-2025)
Table 128. AffinityDNA Recent Developments
Table 129. Endeavour DNA Laboratories Corporation Information
Table 130. Endeavour DNA Laboratories Description and Major Businesses
Table 131. Endeavour DNA Laboratories Product Features and Attributes
Table 132. Endeavour DNA Laboratories Revenue (US$ Million) and Gross Margin (2020-2025)
Table 133. Endeavour DNA Laboratories Recent Developments
Table 134. DDC Corporation Information
Table 135. DDC Description and Major Businesses
Table 136. DDC Product Features and Attributes
Table 137. DDC Revenue (US$ Million) and Gross Margin (2020-2025)
Table 138. DDC Recent Developments
Table 139. Raw Materials Key Suppliers
Table 140. Distributors List
Table 141. Market Trends and Market Evolution
Table 142. Market Drivers and Opportunities
Table 143. Market Challenges, Risks, and Restraints
Table 144. Research Programs/Design for This Report
Table 145. Key Data Information from Secondary Sources
Table 146. Key Data Information from Primary Sources
List of Figures
Figure 1. Sibling DNA Tests Product Picture
Figure 2. Global Sibling DNA Tests Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
Figure 3. Saliva Sample Product Picture
Figure 4. Blood Sample Product Picture
Figure 5. Global Sibling DNA Tests Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
Figure 6. Hospitals
Figure 7. Testing Organizations
Figure 8. Others
Figure 9. Sibling DNA Tests Report Years Considered
Figure 10. Global Sibling DNA Tests Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 11. Global Sibling DNA Tests Revenue (2020-2031) & (US$ Million)
Figure 12. Global Sibling DNA Tests Revenue (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Figure 13. Global Sibling DNA Tests Revenue Market Share by Region (2020-2031)
Figure 14. Global Sibling DNA Tests Revenue Market Share Ranking (2024)
Figure 15. Tier Distribution by Revenue Contribution (2020 VS 2024)
Figure 16. Saliva Sample Revenue Market Share by Player in 2024
Figure 17. Blood Sample Revenue Market Share by Player in 2024
Figure 18. Global Sibling DNA Tests Revenue Market Share by Type (2020-2031)
Figure 19. Global Sibling DNA Tests Revenue Market Share by Application (2020-2031)
Figure 20. North America Sibling DNA Tests Revenue YoY (2020-2031) & (US$ Million)
Figure 21. North America Top 5 Players Sibling DNA Tests Revenue (US$ Million) in 2024
Figure 22. North America Sibling DNA Tests Revenue (US$ Million) by Type (2020 - 2031)
Figure 23. North America Sibling DNA Tests Revenue (US$ Million) by Application (2020-2031)
Figure 24. US Sibling DNA Tests Revenue (2020-2031) & (US$ Million)
Figure 25. Canada Sibling DNA Tests Revenue (2020-2031) & (US$ Million)
Figure 26. Mexico Sibling DNA Tests Revenue (2020-2031) & (US$ Million)
Figure 27. Europe Sibling DNA Tests Revenue YoY (2020-2031) & (US$ Million)
Figure 28. Europe Top 5 Players Sibling DNA Tests Revenue (US$ Million) in 2024
Figure 29. Europe Sibling DNA Tests Revenue (US$ Million) by Type (2020-2031)
Figure 30. Europe Sibling DNA Tests Revenue (US$ Million) by Application (2020-2031)
Figure 31. Germany Sibling DNA Tests Revenue (2020-2031) & (US$ Million)
Figure 32. France Sibling DNA Tests Revenue (2020-2031) & (US$ Million)
Figure 33. U.K. Sibling DNA Tests Revenue (2020-2031) & (US$ Million)
Figure 34. Italy Sibling DNA Tests Revenue (2020-2031) & (US$ Million)
Figure 35. Russia Sibling DNA Tests Revenue (2020-2031) & (US$ Million)
Figure 36. Asia-Pacific Sibling DNA Tests Revenue YoY (2020-2031) & (US$ Million)
Figure 37. Asia-Pacific Top 8 Players Sibling DNA Tests Revenue (US$ Million) in 2024
Figure 38. Asia-Pacific Sibling DNA Tests Revenue (US$ Million) by Type (2020-2031)
Figure 39. Asia-Pacific Sibling DNA Tests Revenue (US$ Million) by Application (2020-2031)
Figure 40. Indonesia Sibling DNA Tests Revenue (2020-2031) & (US$ Million)
Figure 41. Japan Sibling DNA Tests Revenue (2020-2031) & (US$ Million)
Figure 42. South Korea Sibling DNA Tests Revenue (2020-2031) & (US$ Million)
Figure 43. Australia Sibling DNA Tests Revenue (2020-2031) & (US$ Million)
Figure 44. India Sibling DNA Tests Revenue (2020-2031) & (US$ Million)
Figure 45. Indonesia Sibling DNA Tests Revenue (2020-2031) & (US$ Million)
Figure 46. Vietnam Sibling DNA Tests Revenue (2020-2031) & (US$ Million)
Figure 47. Malaysia Sibling DNA Tests Revenue (2020-2031) & (US$ Million)
Figure 48. Philippines Sibling DNA Tests Revenue (2020-2031) & (US$ Million)
Figure 49. Singapore Sibling DNA Tests Revenue (2020-2031) & (US$ Million)
Figure 50. Central and South America Sibling DNA Tests Revenue YoY (2020-2031) & (US$ Million)
Figure 51. Central and South America Top 5 Players Sibling DNA Tests Revenue (US$ Million) in 2024
Figure 52. Central and South America Sibling DNA Tests Revenue (US$ Million) by Type (2020-2031)
Figure 53. Central and South America Sibling DNA Tests Revenue (US$ Million) by Application (2020-2031)
Figure 54. Brazil Sibling DNA Tests Revenue (2020-2025) & (US$ Million)
Figure 55. Argentina Sibling DNA Tests Revenue (2020-2025) & (US$ Million)
Figure 56. Middle East and Africa Sibling DNA Tests Revenue YoY (2020-2031) & (US$ Million)
Figure 57. Middle East and Africa Top 5 Players Sibling DNA Tests Revenue (US$ Million) in 2024
Figure 58. South America Sibling DNA Tests Revenue (US$ Million) by Type (2020-2031)
Figure 59. Middle East and Africa Sibling DNA Tests Revenue (US$ Million) by Application (2020-2031)
Figure 60. GCC Countries Sibling DNA Tests Revenue (2020-2025) & (US$ Million)
Figure 61. Israel Sibling DNA Tests Revenue (2020-2025) & (US$ Million)
Figure 62. Egypt Sibling DNA Tests Revenue (2020-2025) & (US$ Million)
Figure 63. South Africa Sibling DNA Tests Revenue (2020-2025) & (US$ Million)
Figure 64. Sibling DNA Tests Industry Chain Mapping
Figure 65. Channels of Distribution (Direct Vs Distribution)
Figure 66. Bottom-up and Top-down Approaches for This Report
Figure 67. Data Triangulation
Figure 68. Key Executives Interviewed